Related Experiment Video
Updated: Jul 4, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Recent advances in dietary androgen receptor inhibitors
Li Ren1, Tiehua Zhang1, Jie Zhang1
1College of Food Science and Engineering, Jilin University, Changchun, China.
Abstract:
As a nuclear transcription factor, the androgen receptor (AR) plays a crucial role not only in normal male sexual differentiation and growth of the prostate, but also in benign prostatic hyperplasia, prostatitis, and prostate cancer. Multiple population-based epidemiological studies demonstrated that prostate cancer risk was inversely associated with increased dietary intakes of green tea, soy products, tomato, and so forth. Therefore, this review aimed to summarize the structure and function of AR, and further illustrate the structural basis for antagonistic mechanisms of the currently clinically available antiandrogens. Due to the limitations of these antiandrogens, a series of natural AR inhibitors have been identified from edible plants such as fruits and vegetables, as well as folk medicines, health foods, and nutritional supplements. Hence, this review mainly focused on recent experimental, epidemiological, and clinical studies about natural AR inhibitors, particularly the association between dietary intake of natural antiandrogens and reduced risk of prostatic diseases. Since natural products offer multiple advantages over synthetic antiandrogens, this review may provide a comprehensive and updated overview of dietary-derived AR inhibitors, as well as their potential for the nutritional intervention against prostatic disorders.
Insights
Dietary intake of natural compounds can inhibit the androgen receptor (AR), potentially reducing the risk of prostate diseases like cancer. This review explores natural AR inhibitors for nutritional intervention.
Area of Science:
- Endocrinology and Molecular Biology
- Nutritional Science
- Oncology
Background:
- The androgen receptor (AR) is vital for male development and prostate health, but its dysregulation contributes to prostatic diseases, including prostate cancer.
- Epidemiological studies suggest dietary factors, such as green tea and soy, may lower prostate cancer risk.
- Current synthetic antiandrogens have limitations, driving the search for alternative therapies.
Purpose of the Study:
- To review the structure and function of the androgen receptor (AR).
- To elucidate the mechanisms of action for existing antiandrogens.
- To summarize research on natural AR inhibitors from dietary sources and their potential role in preventing prostatic diseases.
Main Methods:
- Literature review of experimental, epidemiological, and clinical studies.
- Analysis of the structural basis for AR antagonism.
- Focus on natural compounds from edible plants, folk medicines, and supplements.
Main Results:
- Natural compounds from edible plants and traditional medicines act as AR inhibitors.
- Dietary intake of natural antiandrogens is associated with a reduced risk of prostatic diseases.
- Natural products present advantages over synthetic antiandrogens.
Conclusions:
- Natural AR inhibitors offer a promising avenue for nutritional intervention against prostatic disorders.
- Further research into dietary-derived AR inhibitors could lead to novel strategies for managing prostate health.
- This review provides an updated overview of natural antiandrogens for preventing prostate diseases.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

